Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN)
Clinical trial NCT02597322 · COMPLETED
Trial details
- NCT number
- NCT02597322
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2015-11-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.